Dabigatran: patient management in specific clinical settings

Dabigatran, a direct thrombin inhibitor, is licensed for the prevention of venous thromboembolism after knee and hip replacement, the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and for the treatment of acute venous thromboembolism. As dabigatran has...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyrle, Paul Alexander, Binder, Konrad, Eichinger, Sabine, Függer, Reinhold, Gollackner, Bernd, Hiesmayr, J. Michael, Huber, Kurt, Lang, Wielfried, Perger, Peter, Quehenberger, Peter, Roithinger, Franz X., Schmaldienst, Sabine, Weltermann, Ansgar, Domanovits, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165862/
https://www.ncbi.nlm.nih.gov/pubmed/25138549
http://dx.doi.org/10.1007/s00508-014-0581-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165862/
https://www.ncbi.nlm.nih.gov/pubmed/25138549
http://dx.doi.org/10.1007/s00508-014-0581-x

Ejemplares similares